CVS drug price overhaul ‘will likely be phased in over several years’, says Gabelli’s Jeff Jonas
Jeff Jonas, Gabelli Funds Portfolio Manager, joins ‘Closing Bell Overtime’ to talk CVS overhauling drug pricing, investing opportunity in the healthcare sector and more.